LAZ Lazard, Inc. Insider Trading

CEO Peter Orszag sells 69,170 shares (69.2K) at $40.76 avg; stock down 23.7% in 30 days, 21.1% in 90 days.

Orszag executed 2 separate sales totaling 69,170 shares for $2,819,273.61, reducing his holdings by 24.7% to 210,942 shares post-transaction. This represents a meaningful reduction in his ownership stake at prices ($40.73 and $41.66) that now trade 2.2% above the current price of $39.89, but within a broader downtrend—the stock is down 23.7% over 30 days and 21.1% over 90 days from these sale dates. His cross-ticker track record shows a 100.00% well-timed rate on prior sells (5 prior transactions with an average 90-day return of -4.3%), and at LAZ specifically, his prior 5 sells were all well-timed at the 90-day mark, with negative average returns ranging from -6.3% to -24.0%. The current price action—trading 30.9% below the 52-week high and down sharply in the recent short-to-medium term—aligns with his demonstrated pattern of selling ahead of declines.

CEO Orszag sells 32,475 LAZ shares at $54.09 for $1.8M; cross-ticker timing record 100% well-timed on 90d basis.

CEO Peter Richard Orszag sold 32,475 shares of Lazard at $54.09, reducing his holdings by 15.1% from 215,749 to 183,274 shares. This is noteworthy given his cross-ticker track record shows 4 prior sells with a 90d well-timed rate of 100.00%, meaning his past sales consistently preceded stock declines over a three-month window. His prior 4 sales at LAZ specifically showed negative 90-day returns (ranging from -1.5% to -6.0%), consistent with the broader pattern of well-timed exits. The stock currently trades at $55.61, only 8.8% below its 52-week high of $61.01, suggesting the CEO is selling into relative strength. Fundamental context shows Lazard posted $796.0M in quarterly revenue with 21.3% annual growth and a P/E of 20.22, providing no obvious distress signal, making this a discretionary sale by the company's top executive during a period of decent operational performance.

CEO Evan L Russo sold 75,000 LAZ shares for $4,240,260.00 in two tranches; his track record shows 100.00% well-timed 90d sells across all tickers.

Evan L Russo, CEO of Asset Management at Lazard, executed 2 separate sales totaling 75,000 shares for $4,240,260.00 on September 10–11, reducing his holdings by 24.8% from 302.9K shares to 227.9K shares. His cross-ticker track record spans 5 prior open-market sells with an average 90-day return of -12.2% and a 90-day well-timed rate of 100.00%, indicating a consistent pattern of selling before subsequent declines. At LAZ specifically, his 5 prior trades show an identical pattern: all 5 prior sells registered negative 90-day returns (ranging from -2.5% to -18.8%), confirming disciplined sell-side timing at this ticker. Against this backdrop, the current sale at a blended price of $56.54, occurring with LAZ at $56.69 and up 5.0% over 30 days and 31.4% over 90 days, is noteworthy: the insider is selling into near-52-week highs (-7.1% from the $61.01 ceiling) and following a strong rally, consistent with his historical execution pattern of liquidating before pullbacks rather than during weakness.

COO Alexandra Soto sold 85,894 shares (43.0% of holdings) at $43.81; stock down 29.3% from 52-week high.

Alexandra Soto, Chief Operating Officer of Lazard Inc., sold 85,894 shares for $3,763,016.14, reducing her holdings from 199,766 shares to 113,872 shares—a 43.0% reduction in position size. The sale occurred at $43.81 per share while the stock currently trades at $43.14, down 29.3% from its 52-week high of $61.01 and down 7.2% over the preceding 30 days. Despite the recent weakness, Lazard's fundamentals remain supportive, with annual revenue growth of 21.3%, a P/E ratio of 15.98, and net income of $60,375,000.00 on quarterly revenue of $648,051,000.00. The sale's significance is moderate, as the COO maintains a substantial remaining position (113,872 shares) while the company's operational performance and valuation do not exhibit distress signals that would typically accompany an insider's complete exit.

CEO Peter Orszag sells 129,078 shares across 4 trades for $5,859,927.27; holdings reduced 43.1% to 170,285 shares

Peter Orszag, CEO & Chairman of Lazard, Inc., executed 4 separate sales totaling 129,078 shares for $5,859,927.27 on March 14 and March 17, 2025, at prices ranging from $44.87 to $45.51. This represents a 43.1% reduction in his shareholdings from 299,363 shares to 170,285 shares. The sales occurred while LAZ trades 25.1% below its 52-week high of $61.01 and 17.2% lower over the past 30 days, suggesting the CEO reduced his exposure during a period of stock price weakness. The company's strong fundamentals—21.3% annual revenue growth, $107.9M in net income, and a favorable 8.42 P/E ratio—do not appear to have constrained this substantial divestiture, warranting investor attention to the reasons behind such a large reduction in executive equity stakes.

CEO Evan L Russo sells 125,000 LAZ shares across 4 transactions for $6.7M, reducing holdings 86.6%

Evan L Russo, CEO of Asset Management at Lazard, Inc., executed 4 separate open-market sales totaling 125,000 shares for $6,740,424.50 (blended average $53.92) between 2025-02-12 and 2025-02-14, reducing his post-transaction holdings to 19,336 shares from 144,336 shares. This -86.6% reduction in his position is material and exceeds typical executive trimming activity. His cross-ticker track record shows 1 prior sell with a 90-day well-timed rate of 100.00%, and his single prior LAZ transaction (2024-03-13 sell) was also well-timed at the 90-day mark. Against this backdrop, the company is trading at $55.24 (near its 52-week high of $61.01) while facing headwinds: annual revenue declined 9.3% year-over-year, net income was negative over the most recent full fiscal year, and the P/E of 24.23 reflects elevated valuation despite deteriorating profitability. The concurrent near-52-week-high prices at which Russo sold align with his demonstrated timing pattern, though the magnitude of this liquidation and the company's negative annual earnings warrant close investor attention.

Executive Chairman Kenneth Jacobs sells 189,004 shares (189.0K) for $9.1M at Lazard across 6 transactions.

Kenneth M Jacobs, Executive Chairman, executed 6 separate sales on September 3–4, 2024, totaling 189,004 shares for $9,093,609.95 at blended average price $48.11. This represents an 11.0% reduction in his holdings (from 1.71M to 1.52M shares). The stock has risen 9.1% over the prior 30 days and 26.3% over 90 days, and stands -3.6% from its 52-week high of $50.11. His cross-ticker track record shows 14 prior sells averaging +0.4% returns over 30 days and +21.9% over 90 days, with a well-timed rate of 0.00%, indicating his prior sales have generally not preceded price declines. The company reported full-year net income was negative despite the latest quarter showing $685.3M revenue and $49.9M net income, and year-over-year annual revenue declined 9.3%, with a P/E of 34.76 and market cap of $5.4B.

Lazard Executive Chairman Kenneth M. Jacobs sells 142,996 shares (34.1% of holdings) in 4 transactions for $7.2M at $50.02 average

Kenneth M. Jacobs, Executive Chairman of Lazard, executed 4 separate sales totaling 142,996 shares for $7,152,207.10 across August 23–26, 2024, at a blended average price of $50.02. This reduces his post-transaction holdings to 276,010 shares, a 34.1% reduction in stake. The sales occurred near the company's 52-week high (stock was -0.5% from the $49.88 peak) and represent the largest concentrated reduction in his observable holdings across the recent filing period. Company fundamentals show material headwinds: annual revenue declined 9.3% year-over-year, net income was negative over the full fiscal year, and the P/E of 35.69 reflects elevated valuation relative to profitability. His prior 5 trades at LAZ have shown mixed timing outcomes, with three showing positive 30-day returns (+5.8% and +10.8%) but only recent near-term price action as reference; post-trade price of $49.61 sits below the transaction average, providing no immediate favorable reversal signal for this specific filing.

Executive Chairman Jacobs sells 334,000 LAZ shares (50.3% of holdings) for $15.1M at $45.23

JACOBS KENNETH M, Executive Chairman of Lazard, Inc., filed a Form 4 disclosing 2 separate sales totaling 334,000 shares (334.0K shares) for $15,105,818.00 ($15.1M) on 2024-07-16, reducing his holdings from 664,279 shares to 330,279 shares. The sale occurred at $45.23 per share, near the 52-week high of $45.49, while the company faces a -9.3% annual revenue decline and reported negative full-year net income. This represents a substantial reduction—50.3% of pre-transaction holdings—executed while stock price momentum remains positive (30-day change: +19.5%; 90-day change: +18.7%), which contrasts with fundamental deterioration and prior timing outcomes at this ticker showing mixed results (-2.5% and -7.4% 30-day returns on recent June and May sales). The magnitude and timing of this divesting warrant investor scrutiny given the company's profitability headwinds and the executive's large stake reduction.

Executive Chairman Kenneth Jacobs sells 74,395 shares at $40.19 for $2,989,585.40 across 2 transactions; holds 457,279 shares post-sale.

Kenneth M. Jacobs, Executive Chairman of Lazard, executed 2 separate sales totaling 74,395 shares for $2,989,585.40 at a blended average price of $40.19 on 2024-07-09, reducing his holdings by 14.0% to 457,279 shares. The company faces mixed headwinds: revenue declined 9.3% year-over-year to $764,753,000.00 in the latest quarter, and the company was unprofitable over its most recent full fiscal year, despite current-quarter net income of $35,755,000.00. Jacobs's prior 5 trades at LAZ have shown modest negative returns (ranging -2.5% to -7.4% over 30 days), and his cross-ticker track record across 6 prior open-market sells averaged -5.0% 30-day returns. The stock is currently priced at $41.30, within 1.4% of its 52-week high and up 9.0% over 30 days, providing context on near-term momentum at the time of sale.